"The ability to detect neutralizing antibodies can help us gain additional insight into what the existence of antibodies may mean for patients as we continue the fight against COVID-19," Dr. Tim Stenzel of the FDA said in a statement.
If fully approved, it would be the first drug to slow cognitive decline in people living with the disease and the first new treatment for Alzheimer's in nearly 20 years.
Virgin Galactic CEO Michael Colglazier on Thursday said he sees the company bringing in up to $1 billion in annual revenue per spaceport in the years ahead.
President Donald Trump is trailing Joe Biden in Nevada and Arizona and is facing a surge in ballots for the Democratic nominee in Pennsylvania and Georgia.
"It has got to end at some point for the good of the country. You've got to have a transfer of power and pull together," former Sen. Joe Lieberman told CNBC.
CNBC's Shepard Smith on Thursday breaks into President Donald Trump's press conference — where the president made claims of rampant voter fraud, without providing evidence — to fact check what he said.
Get complete CNBC business news coverage online. Find the latest regional business news pertaining to the United States of America including headlines & top stories available on the official CNBC site.